Strs Ohio raised its position in LeMaitre Vascular Inc (NASDAQ:LMAT) by 16.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 22,500 shares of the medical instruments supplier’s stock after purchasing an additional 3,200 shares during the period. Strs Ohio’s holdings in LeMaitre Vascular were worth $716,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of LMAT. Swiss National Bank purchased a new position in LeMaitre Vascular in the 2nd quarter valued at about $777,000. JPMorgan Chase & Co. boosted its position in LeMaitre Vascular by 175.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 55,979 shares of the medical instruments supplier’s stock valued at $1,748,000 after buying an additional 35,656 shares during the last quarter. Alliancebernstein L.P. purchased a new position in LeMaitre Vascular in the 2nd quarter valued at about $331,000. Teachers Advisors LLC boosted its position in LeMaitre Vascular by 26.5% in the 2nd quarter. Teachers Advisors LLC now owns 27,724 shares of the medical instruments supplier’s stock valued at $866,000 after buying an additional 5,806 shares during the last quarter. Finally, TIAA CREF Investment Management LLC boosted its position in LeMaitre Vascular by 10.6% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 116,349 shares of the medical instruments supplier’s stock valued at $3,632,000 after buying an additional 11,192 shares during the last quarter. 71.64% of the stock is owned by institutional investors.

A number of research firms have weighed in on LMAT. BidaskClub raised shares of LeMaitre Vascular from a “hold” rating to a “buy” rating in a research report on Wednesday. Zacks Investment Research cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Stifel Nicolaus reissued a “buy” rating on shares of LeMaitre Vascular in a research report on Sunday, October 29th. Finally, Canaccord Genuity decreased their price objective on shares of LeMaitre Vascular from $30.00 to $29.00 and set a “hold” rating for the company in a research report on Friday, October 27th. Six research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $32.20.

Shares of LeMaitre Vascular Inc (NASDAQ LMAT) opened at $33.51 on Friday. The stock has a market cap of $660.59, a PE ratio of 44.53, a PEG ratio of 2.64 and a beta of 0.53. LeMaitre Vascular Inc has a 12 month low of $19.82 and a 12 month high of $39.88.

COPYRIGHT VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/09/strs-ohio-has-716000-holdings-in-lemaitre-vascular-inc-lmat.html.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Want to see what other hedge funds are holding LMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LeMaitre Vascular Inc (NASDAQ:LMAT).

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.